| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/TP.0B013E3182921995 |
| P698 | PubMed publication ID | 23778568 |
| P50 | author | Bruno Moulin | Q42713554 |
| P2093 | author name string | Sophie Caillard | |
| Jérôme Olagne | |||
| Claire Borni-Duval | |||
| Françoise Heibel | |||
| Laura Braun-Parvez | |||
| Peggy Perrin | |||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1498-1505 | |
| P577 | publication date | 2013-06-01 | |
| P1433 | published in | Transplantation | Q15730500 |
| P1476 | title | Risk factors for BK virus infection in the era of therapeutic drug monitoring | |
| P478 | volume | 95 |
| Q38801394 | 45 years after the discovery of human polyomaviruses BK and JC: Time to speed up the understanding of associated diseases and treatment approaches |
| Q33793057 | A delicate balance between rejection and BK polyomavirus associated nephropathy; A retrospective cohort study in renal transplant recipients |
| Q37340200 | BK Polyomavirus Replication in Renal Tubular Epithelial Cells Is Inhibited by Sirolimus, but Activated by Tacrolimus Through a Pathway Involving FKBP-12. |
| Q37375153 | BK Polyomavirus and the Transplanted Kidney: Immunopathology and Therapeutic Approaches |
| Q39180715 | BK Polyomavirus: Clinical Aspects, Immune Regulation, and Emerging Therapies. |
| Q54220017 | BK Virus Infection in Thai Kidney Transplant Recipients: A Single-Center Experience. |
| Q59361019 | BK Virus: A Cause for Concern in Thoracic Transplantation? |
| Q28070240 | BK nephropathy in the native kidneys of patients with organ transplants: Clinical spectrum of BK infection |
| Q56957209 | BKV, CMV, and EBV Interactions and their Effect on Graft Function One Year Post-Renal Transplantation: Results from a Large Multi-Centre Study |
| Q37345783 | Characterization of Immunodominant BK Polyomavirus 9mer Epitope T Cell Responses |
| Q90704743 | Conversion From Mycophenolates to Mizoribine Is Associated With Lower BK Virus Load in Kidney Transplant Recipients: A Prospective Study |
| Q40955618 | Different risk factor profiles distinguish early-onset from late-onset BKV-replication |
| Q39152770 | Early steroid withdrawal results in improved patient and graft survival and lower risk of post-transplant cardiovascular risk profiles: A single-center 10-year experience |
| Q38792824 | Evaluation of the predisposition and clinical impact of BK virus replication in kidney transplant patients |
| Q40537031 | Incidence of BK polyomavirus infection after kidney transplantation is independent of type of immunosuppressive therapy. |
| Q40827412 | Increased gene expression of TGF-β in peripheral blood mononuclear cells from renal transplant patients with polyomavirus BK viremia |
| Q92500183 | Intravenous Immunoglobulin Administration Significantly Increases BKPyV Genotype-Specific Neutralizing Antibody Titers in Kidney Transplant Recipients |
| Q41001229 | Minimization of maintenance immunosuppressive therapy after renal transplantation comparing cyclosporine A/azathioprine or cyclosporine A/mycophenolate mofetil bitherapy to cyclosporine A monotherapy: a 10-year postrandomization follow-up study. |
| Q26823090 | New directions for rabbit antithymocyte globulin (Thymoglobulin(®)) in solid organ transplants, stem cell transplants and autoimmunity |
| Q90482752 | Optimizing Mycophenolic Acid Exposure in Kidney Transplant Recipients: Time for Target Concentration Intervention |
| Q37399679 | Outcomes of renal transplant recipients with BK virus infection and BK virus surveillance in the Auckland region from 2006 to 2012. |
| Q40649540 | Pretransplantation Donor-Recipient Pair Seroreactivity Against BK Polyomavirus Predicts Viremia and Nephropathy After Kidney Transplantation. |
| Q40274842 | Prevalence and Risk Factors of BK Viremia in Patients With Kidney Transplantation: A Single-Center Experience From Turkey |
| Q40929519 | Risk Factors for the Development of BK Virus Nephropathy in Renal Transplant Recipients |
| Q41604365 | Risk factors for BK virus infection and BK virus-associated nephropathy under the impact of intensive monitoring and pre-emptive immunosuppression reduction |
| Q59355888 | Risk factors for BK virus infection in living-donor renal transplant recipients: a single-center study from China |
| Q36297604 | Sequence Variation in Amplification Target Genes and Standards Influences Interlaboratory Comparison of BK Virus DNA Load Measurement. |
| Q40513496 | Successful renal retransplantation after graft loss from BK polyomavirus infection in a human immunodeficiency virus-positive patient |
| Q42217747 | Successful treatment of BK virus nephropathy using therapeutic drug monitoring of mycophenolic acid |
| Q41385328 | The Loss of BKV-specific Immunity From Pretransplantation to Posttransplantation Identifies Kidney Transplant Recipients at Increased Risk of BKV Replication. |
| Q38752528 | The compelling case for therapeutic drug monitoring of mycophenolate mofetil therapy |
| Q40670409 | The effect of rituximab dose on infectious complications in ABO-incompatible kidney transplantation. |
| Q38578386 | The safety of calcineurin inhibitors for kidney-transplant patients |
| Q34395610 | The tacrolimus metabolism rate influences renal function after kidney transplantation |
| Q41710377 | Toward standardization of BK virus monitoring: evaluation of the BK virus R-gene kit for quantification of BK viral load in urine, whole-blood, and plasma specimens. |
Search more.